Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Deciphera Pharmaceuticals LLC stock
Learn how to easily invest in Deciphera Pharmaceuticals LLC stock.
Deciphera Pharmaceuticals LLC is a drug manufacturers-specialty & generic business based in the US. Deciphera Pharmaceuticals LLC shares (DCPH) are listed on the NASDAQ and all prices are listed in US Dollars. Deciphera Pharmaceuticals LLC employs 300 staff and has a trailing 12-month revenue of around $138.3 million.
How to buy Deciphera Pharmaceuticals LLC stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – DCPH. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Commission-free stock and ETF trades
- No management fees
- Customizable portfolios with automatic rebalancing
Deciphera Pharmaceuticals LLC stock price (NASDAQ: DCPH)Use our graph to track the performance of DCPH stocks over time.
Deciphera Pharmaceuticals LLC shares at a glance
|Latest market close||$14.08|
|52-week range||$10.14 - $22.76|
|50-day moving average||$14.42|
|200-day moving average||$16.14|
|Wall St. target price||$21.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.25|
Buy Deciphera Pharmaceuticals LLC stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Deciphera Pharmaceuticals LLC stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Deciphera Pharmaceuticals LLC price performance over time
Historical closes compared with the close of $14.08 from 2023-06-02
|1 week (2023-05-30)||3.53%|
|1 month (2023-05-05)||4.14%|
|3 months (2023-03-06)||-6.69%|
|6 months (2022-12-06)||-6.51%|
|1 year (2022-06-03)||25.60%|
|2 years (2021-06-04)||-57.22%|
|3 years (2020-06-05)||55.19|
|5 years (2018-06-06)||41.52|
Deciphera Pharmaceuticals LLC financials
|Revenue TTM||$138.3 million|
|Gross profit TTM||$-62,555,000|
|Return on assets TTM||-25.29%|
|Return on equity TTM||-51.05%|
|Market capitalisation||$1.1 billion|
TTM: trailing 12 months
Deciphera Pharmaceuticals LLC share dividends
We're not expecting Deciphera Pharmaceuticals LLC to pay a dividend over the next 12 months.
Deciphera Pharmaceuticals LLC share price volatility
Over the last 12 months, Deciphera Pharmaceuticals LLC's shares have ranged in value from as little as $10.14 up to $22.76. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Deciphera Pharmaceuticals LLC's is 0.6749. This would suggest that Deciphera Pharmaceuticals LLC's shares are less volatile than average (for this exchange).
Deciphera Pharmaceuticals LLC overview
Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company, engages in the discovering, developing, and commercializing medicines to improve the lives of cancer patients in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 in combination with RTK/RAS/MAP kinase signaling pathway inhibition to treat RAS/RAF mutant cancers. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. .
Deciphera Pharmaceuticals LLC in the news
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 3.6% Since Last Earnings Report?
Deciphera Pharmaceuticals to Present Data from INTRIGUE Phase 3 Study of QINLOCK® (ripretinib) and Trial-in-Progress Poster for INSIGHT Pivotal Phase 3 Study of QINLOCK® at the 2023 American Society of Clinical Oncology Annual Meeting
Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
Frequently asked questionsWhat percentage of Deciphera Pharmaceuticals LLC is owned by insiders or institutions?
Currently 29.987% of Deciphera Pharmaceuticals LLC shares are held by insiders and 73.087% by institutions. How many people work for Deciphera Pharmaceuticals LLC?
Latest data suggests 300 work at Deciphera Pharmaceuticals LLC. When does the fiscal year end for Deciphera Pharmaceuticals LLC?
Deciphera Pharmaceuticals LLC's fiscal year ends in December. Where is Deciphera Pharmaceuticals LLC based?
Deciphera Pharmaceuticals LLC's address is: 200 Smith Street, Waltham, MA, United States, 02451 What is Deciphera Pharmaceuticals LLC's ISIN number?
Deciphera Pharmaceuticals LLC's international securities identification number is: US24344T1016 What is Deciphera Pharmaceuticals LLC's CUSIP number?
Deciphera Pharmaceuticals LLC's Committee on Uniform Securities Identification Procedures number is: 24344T101
More guides on Finder
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Ask an Expert